{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T04:36:11Z","timestamp":1767414971743,"version":"3.41.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.prostaglandins.2018.01.003","type":"journal-article","created":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T17:37:03Z","timestamp":1518889023000},"page":"36-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Lysophosphatidic acid in medicinal herbs enhances prostaglandin E2 and protects against indomethacin-induced gastric cell damage in vivo and in vitro"],"prefix":"10.1016","volume":"135","author":[{"given":"Sheuli","family":"Afroz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayano","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouki","family":"Fujikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Motiur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Morito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Fukuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emi","family":"Kiyokage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Toida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuhiro","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Kogure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Tokumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamotsu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0005","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/bies.20081","article-title":"The ins and outs of lysophosphatidic acid signaling","volume":"26","author":"Moolenaar","year":"2004","journal-title":"Bioessays"},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0010","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1194\/jlr.R046458","article-title":"LPA receptor signaling: pharmacology, physiology, and pathophysiology","volume":"55","author":"Yung","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0015","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1248\/jhs.57.115","article-title":"Physiological significance of lysophospholipids that act on the lumen side of mammalian lower digestive tracts","volume":"57","author":"Tokumura","year":"2011","journal-title":"J. Health Sci."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0020","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.yexcr.2014.11.013","article-title":"Diverse roles of LPA signaling in the intestinal epithelium","volume":"333","author":"Yun","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0025","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.20050421","article-title":"Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactions","volume":"202","author":"Li","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0030","doi-asserted-by":"crossref","first-page":"G182","DOI":"10.1152\/ajpgi.00345.2009","article-title":"Mechanisms of lysophosphatidic acid (LPA) mediated stimulation of intestinal apical Cl\u2212\/OH\u2212 exchange","volume":"298","author":"Singla","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0035","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1053\/gast.2002.34209","article-title":"Lysophosphatidic acid protects and rescues intestinal epithelial cells from radiation- and chemotherapy-induced apoptosis","volume":"123","author":"Deng","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0040","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1053\/j.gastro.2007.03.038","article-title":"The lysophosphatidic acid type 2 receptor is required for protection against radiation-induced intestinal injury","volume":"132","author":"Deng","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0045","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1128\/MCB.00038-13","article-title":"Distinct phospholipase C-\u03b2 isozymes mediate lysophosphatidic acid receptor 1 effects on intestinal epithelial homeostasis and wound closure","volume":"33","author":"Lee","year":"2013","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0050","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/00001574-200411000-00004","article-title":"Gastroduodenal mucosal defense: role of endogenous mediators","volume":"20","author":"Kaunitz","year":"2004","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1053\/j.gastro.2008.05.030","article-title":"Gastric mucosal defense: and cytoprotection: bench to bedside","volume":"135","author":"Laine","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0060","first-page":"21","article-title":"Nonsteroidal anti-inflammatory drugs: benefits, risks, and COX-2 selectivity","volume":"18","author":"Halverson","year":"1999","journal-title":"Orthop. Nurs."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0065","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1365-2036.2009.04086.x","article-title":"Review article: cellular and molecular mechanisms of NSAID-induced peptic ulcers","volume":"30","author":"Musumba","year":"2009","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0070","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1007\/s10620-012-2475-y","article-title":"Orally administrated phosphatidic acid and lysophosphatidic acids ameliorate aspirin-induced stomach mucosal injury in mice","volume":"58","author":"Tanaka","year":"2013","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0075","doi-asserted-by":"crossref","first-page":"6950","DOI":"10.1021\/acs.jafc.6b02884","article-title":"Concentrated phosphatidic acid in cereal brans as potential protective agents against indomethacin-induced stomach ulcer","volume":"64","author":"Afroz","year":"2016","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0080","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/biof.1147","article-title":"Type 2 lysophosphatidic acid receptor in gastric surface mucous cells: possible implication of prostaglandin E2 production","volume":"40","author":"Tanaka","year":"2014","journal-title":"Biofactors"},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0085","doi-asserted-by":"crossref","first-page":"17020","DOI":"10.3748\/wjg.v20.i45.17020","article-title":"Efficacy and safety of herbal medicines in treating gastric ulcer: a review","volume":"20","author":"Bi","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0090","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1007\/s10620-011-1595-0","article-title":"Intragastrically administrated lysophosphatidic acid protect against gastric ulcer in rats under water-immersion restraint stress","volume":"56","author":"Adachi","year":"2011","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0095","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1271\/bbb.80813","article-title":"Formation of lysophosphatidic acid, a wound-healing lipid, during digestion of cabbage leaves","volume":"73","author":"Tanaka","year":"2009","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0100","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/y59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0105","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0003-2697(70)90352-0","article-title":"Determination of lipid phosphorus in the nanomolar range","volume":"36","author":"Chalvardjian","year":"1970","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0110","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/BF02669968","article-title":"Phospholipid content of foods","volume":"60","author":"Weihrauch","year":"1983","journal-title":"J. Am. Oil Chem. Soc."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0115","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.bbalip.2011.07.009","article-title":"Enzymatic formation of N-acylethanolamines from N-acylethanolamine plasmalogen through N-acylphosphatidylethanolamine-hydrolyzing phospholipase D-dependent and \u2212independent pathways","volume":"1811","author":"Tsuboi","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0120","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1021\/jf300147y","article-title":"Quantification of phosphatidic acid in foodstuffs using a thin-layer-chromatography-imaging technique","volume":"60","author":"Tanaka","year":"2012","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0125","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/sj.bjc.6690062","article-title":"Non-steroidal anti-inflammatory drug-induced apoptosis in gastric cancer cells is blocked by protein kinase C activation through inhibition of c-myc","volume":"79","author":"Zhu","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0130","doi-asserted-by":"crossref","first-page":"G1092","DOI":"10.1152\/ajpgi.2001.281.4.G1092","article-title":"NSAIDs induce both necrosis and apoptosis in guinea pig gastric mucosal cells in primary culture","volume":"281","author":"Tomisato","year":"2001","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0135","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/0016-5085(81)90139-6","article-title":"Gastric gel mucus thickness: effect of distention, 16, 16-dimethyl prostaglandin E2, and carbenoxolone","volume":"80","author":"Bickel","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0140","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s11101-012-9262-4","article-title":"The therapeutical lead potential of metabolites obtained from natural sources for the treatment of peptic ulcer","volume":"11","author":"Junior","year":"2012","journal-title":"Phytochem. Rev."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0145","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.3390\/ijms13033203","article-title":"Tannins, peptic ulcers and related mechanisms","volume":"13","author":"Jesus","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0150","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s10620-012-2530-8","article-title":"Role of phospholipids in protection of the GI mucosa","volume":"58","author":"Lichtenberger","year":"2013","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0155","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0022-3565(24)38925-6","article-title":"Induction of cyclooxygenase-2 in rat gastric mucosa by rebamipide, a mucoprotective agent","volume":"295","author":"Sun","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0160","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1007\/s10620-006-9661-8","article-title":"Geranylgeranylacetone induces cyclooxygenase-2 expression in cultured rat gastric epithelial cells through NF-kappaB","volume":"52","author":"Nishida","year":"2007","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0165","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1016\/j.febslet.2010.08.035","article-title":"Lysophosphatidic acid stimulates gastric cancer cell proliferation via ERK1-dependent upregulation of sphingosine kinase 1 transcription","volume":"584","author":"Ramachandran","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0170","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1038\/sj.onc.1208665","article-title":"Mitogenic signaling by lysophosphatidic acid (LPA) involves G alpha 12","volume":"24","author":"Radhika","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0175","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.bbagen.2007.08.008","article-title":"Lysophospholipid signaling: beyond the EDGs","volume":"1780","author":"Valentine","year":"2008","journal-title":"Biochem. Biophys. Acta"},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0180","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1371\/journal.pbio.0040276","article-title":"Disruption-induced mucus secretion: repair and protection","volume":"4","author":"Miyake","year":"2006","journal-title":"PLoS Biol."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0185","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3858\/emm.2008.40.6.607","article-title":"Lysophosphatidic acid receptor 2 and Gi\/Src pathway mediate cell motility through cyclooxygenase 2 expression in CAOV-3 ovarian cancer cells","volume":"40","author":"Jeong","year":"2008","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0190","doi-asserted-by":"crossref","first-page":"C2","DOI":"10.1152\/ajpcell.00610.2004","article-title":"LPA2 receptor mediates mitogenic signals in human colon cancer cells","volume":"289","author":"Yun","year":"2005","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0195","doi-asserted-by":"crossref","first-page":"23589","DOI":"10.1074\/jbc.M603670200","article-title":"GPR92 as a new G12\/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP","volume":"281","author":"Lee","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0200","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1124\/jpet.105.098848","article-title":"Lysophosphatidic acid binds to and activates GPR92 a G protein-coupled receptor highly expressed in gastrointestinal lymphocytes","volume":"318","author":"Kotarsky","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0205","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1194\/jlr.M200242-JLR200","article-title":"Lysophosphatidic acid, a growth factor-like lipid, in the saliva","volume":"43","author":"Sugiura","year":"2002","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0076-6879(07)33001-2","article-title":"Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis","volume":"433","author":"Murph","year":"2007","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0215","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1258\/acb.2008.007242","article-title":"Measurement of plasma lysophosphatidic acid concentration in healthy subjects: strong correlation with lysophospholipase D activity","volume":"45","author":"Hosogaya","year":"2008","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0220","doi-asserted-by":"crossref","first-page":"48737","DOI":"10.1074\/jbc.M206812200","article-title":"Serum lysophosphatidic acid is produced through diverse phospholipase pathways","volume":"277","author":"Aoki","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prostaglandins.2018.01.003_bib0225","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0014-5793(00)01827-5","article-title":"Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors","volume":"478","author":"Bandoh","year":"2000","journal-title":"FEBS Lett."}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882317301405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882317301405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T22:09:05Z","timestamp":1751407745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882317301405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":45,"alternative-id":["S1098882317301405"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2018.01.003","relation":{},"ISSN":["1098-8823"],"issn-type":[{"type":"print","value":"1098-8823"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lysophosphatidic acid in medicinal herbs enhances prostaglandin E2 and protects against indomethacin-induced gastric cell damage in vivo and in vitro","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2018.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}